Health Access, Medicaid, and New Treatments

Kilder

• Kff: Examining LGBTQ+ Adults’ Experiences with Health Care Costs and Access
• STAT: STAT+: Hospitals plot their response to funding cuts
• STAT: Hospitals are plotting a long-shot push to roll back $1 trillion in Medicaid cuts
• Beckershospitalreview: Intermountain Medical Center adds new MRI for heart, cancer care
• Ksl: New MRI machine uses AI to reduce time, make clearer images at Intermountain Medical Center - KSL
• Kff: Global COVID-19 Tracker
• STAT: STAT+: CMS plans launch event for ACCESS, the Medicare chronic care pilot
• STAT: STAT+: FDA approves Roivant therapy for rare autoimmune disease
• Stockhouse: 2026-08-27 | Roivant Announces FDA Approval of LISRAYA(TM) (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S. | NDAQ:ROIV | Press Release - Stockhouse
• Tipranks: Roivant Gains FDA Approval for LISRAYA Dermatomyositis Therapy - TipRanks

Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.